La. Public Health and Safety § 40:1169.4
Current with changes from the 2024 legislative session effective on or before 7/1/2024, from Acts 1-3, 6-671
Section 40:1169.4 - Availability of drugs, biological products, and devices; costs; insurance coverageA.(1) A manufacturer of an investigational drug, biological product, or device may make available such drug, product, or device to eligible patients in accordance with the provisions of this Section.(2) Nothing in this Section shall be construed to require a manufacturer to make available any drug, product, or device.B. A manufacturer may do any of the following:(1) Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation.(2) Require an eligible patient to pay the costs of or associated with the manufacture of the investigational drug, biological product, or device.C.(1) A health insurance issuer may choose to provide coverage for the cost of an investigational drug, biological product, or device.(2) Nothing in this Section shall be construed to require a health insurance issuer to provide coverage for the cost of any investigational drug, biological product, or device.La. Public Health and Safety § 40:1169.4
Acts 2014, No. 346, §1; Redesignated from R.S. 40:1300.424 by HCR 84 of 2015 R.S. Acts 2014, No. 346, §1; Redesignated from R.S. 40:1300.424 by HCR 84 of 2015 R.S.